Raymond W Nims

InstitutionRMC Pharmaceutical Solutions
AddressLongmont
Colorado
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in March 2021
    All Publications
    Bar chart showing 48 publications over 18 distinct years, with a maximum of 9 publications in 1994
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ijaz MK, Nims RW, McKinney J. SARS-CoV-2 mutational variants may represent a new challenge to society, but not to the virucidal armamentarium. J Hosp Infect. 2021 06; 112:121-123. PMID: 33766545.
      Citations: 1     Fields:    Translation:Humans
    2. Ijaz MK, Nims RW, Zhou SS, Whitehead K, Srinivasan V, Kapes T, Fanuel S, Epstein JH, Daszak P, Rubino JR, McKinney J. Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses. Sci Rep. 2021 03 11; 11(1):5626. PMID: 33707476.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    3. Ijaz MK, Nims RW, McKinney J. Indirect transmission of severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2): What do we know and what do we not know? Infect Control Hosp Epidemiol. 2021 Feb 09; 1-2. PMID: 33557961.
      Citations: 1     Fields:    
    4. Cutts TA, Nims RW, Theriault SS, Bruning E, Rubino JR, Ijaz MK. Hand hygiene: virucidal efficacy of a liquid hand wash product against Ebola virus. Infect Prev Pract. 2021 Mar; 3(1):100122. PMID: 34368739.
      Citations: 1     
    5. Ijaz MK, Sattar SA, Rubino JR, Nims RW, Gerba CP. Combating SARS-CoV-2: leveraging microbicidal experiences with other emerging/re-emerging viruses. PeerJ. 2020; 8:e9914. PMID: 33194365.
      Citations: 4     
    6. Ijaz MK, Whitehead K, Srinivasan V, McKinney J, Rubino JR, Ripley M, Jones C, Nims RW, Charlesworth B. Microbicidal actives with virucidal efficacy against SARS-CoV-2. Am J Infect Control. 2020 08; 48(8):972-973. PMID: 32461067.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health